AI breakthrough could spark medical revolution

UK life science attracts £850m deal

The Heart of AI

Odyssey buys BenevolentAI in Europe's top SPAC deal

VC Firms Have Long Backed AI. Now, They Are Using It.

Family Offices Become Serious Rivals to VC Firms

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

Government to nurture AI-specializing medical scientists

Venture capitalists raise more than $100bn to target life sciences

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement